Ocugen Stock (NASDAQ: OCGN) stock price, news, charts, stock research, profile.
Open | $1.150 |
Close | $1.180 |
Volume / Avg. | 6.856M / 9.101M |
Day Range | 1.110 - 1.250 |
52 Wk Range | 0.345 - 2.105 |
Market Cap | $301.071M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 21.89% |
Days to Cover | 2.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocugen (NASDAQ: OCGN) through any online brokerage.
Other companies in Ocugen’s space includes: Renovaro (NASDAQ:RENB), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and RAPT Therapeutics (NASDAQ:RAPT).
The latest price target for Ocugen (NASDAQ: OCGN) was reported by Chardan Capital on Monday, April 22, 2024. The analyst firm set a price target for 5.00 expecting OCGN to rise to within 12 months (a possible 327.35% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Ocugen (NASDAQ: OCGN) is $1.17 last updated Today at April 25, 2024 at 5:59 PM EDT.
There are no upcoming dividends for Ocugen.
Ocugen’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Ocugen.
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.